Madison Avenue Partners, LP Keros Therapeutics, Inc. Transaction History
Madison Avenue Partners, LP
- $934 Million
- Q2 2025
A detailed history of Madison Avenue Partners, LP transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Madison Avenue Partners, LP holds 2,691,465 shares of KROS stock, worth $36.9 Million. This represents 3.85% of its overall portfolio holdings.
Number of Shares
2,691,465Holding current value
$36.9 Million% of portfolio
3.85%Shares
1 transactions
Others Institutions Holding KROS
# of Institutions
156Shares Held
39.4MCall Options Held
774KPut Options Held
992K-
Adar1 Capital Management, LLC Austin, TX5.39MShares$73.9 Million11.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.63MShares$36.1 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$35.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$34.5 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA2MShares$27.4 Million3.45% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $353M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...